Eisai: Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease Accepted by European Medicines Agency
TOKYO and CAMBRIDGE, Mass., Ja […]
KUCHING, MALAYSIA, Jan 27, 202 […]
Toyota City, Japan, Jan 27, 20 […]
DALLAS, TX, Jan 26, 2023 ̵ […]
TOKYO, Jan 26, 2023 – (J […]
TORONTO, ON, Jan 26, 2023 R […]
TOKYO, Jan 26, 2023 – (J […]
HONG KONG, Jan 26, 2023 – […]...
HONG KONG, Jan 26, 2023 – […]
Singapore, Jan 26, 2023 – […]
TOKYO, Jan 26, 2023 – (J […]
MIAMI, FL, Jan 25, 2023 – […]
MIAMI, FL, Jan 25, 2023 – […]
Zug, Switzerland, January 25, […]